RAAB G KIRK 4
4 · Transcept Pharmaceuticals Inc · Filed Feb 4, 2010
Insider Transaction Report
Form 4
RAAB G KIRK
Director
Transactions
- Award
Common Stock Option (right to buy)
2010-02-03+17,500→ 17,500 totalExercise: $8.07Exp: 2020-02-03→ Common Stock (17,500 underlying)
Footnotes (1)
- [F1]The option vests in twenty-four equal monthly installments beginning March 3, 2010.